Skip to content
Everfront Biotech Inc.

Everfront Biotech Inc.

  • 關於長弘
    • 創辦人的話
  • 新藥開發
    • EF-001 | 治療高度惡性腦瘤
    • EF-009 | 治療胰臟癌
  • 智慧財產
  • 最新消息
  • 聯絡我們
  • HOME 🇺🇸
  • About EFB 🇺🇸
  • Pipelines 🇺🇸
    • EF-001
    • EF-009

產品研發

產品研發 

A. Cerebraca Wafer 對抗人類惡性腦膠質瘤

2019-09-032020-12-29 jacky

“標靶”藥物暨投遞裝置Cerebraca

Read more
產品研發 

B. HK-001對抗漸凍症

2019-09-032020-12-29 jacky

HK-001由調控自體吞噬作用來延緩肌萎

Read more
產品研發 

C. EF-009對抗胰臟癌

2019-09-032019-12-12 jacky

小分子”DNA甲基轉移酶”EF-009

Read more
產品研發 

D. EF-005對抗阿茲海默症

2019-09-032019-12-12 jacky

阿茲海默症iPS 幹細胞篩選出治療之新穎

Read more
產品研發 

產品研發

2019-09-032022-06-06 jacky

A. Cerebraca Wafer 對

Read more

EN NEWS

  • Local delivery therapy of Cerebraca® Wafer being highlighted in the natural review
    2022-06-27
  • Case report – Cerebraca® Wafer implantation combined with CIK therapy for the treatment of recurrent Glioblastoma revealed superior clinical outcome (overall survival extended for more than 24 months).
    2022-06-27
  • Case report – Cerebraca® Wafer implantation for the treatment of un-resectable cervical spine Glioblastoma resulted in the tumor regression.
    2022-06-27
  • Outstanding clinical outcomes were published in various journals. We have listed as follows:
    2022-06-27

長弘生物科技鎖定未被滿足的醫療需求。

致力開發孤兒藥,以治療世上最致命的病症。

Everfront Biotech Inc. is committed to fulfilling unmet medical needs by developing orphan drugs to treat the world’s most lethal diseases.

與我們聯絡:

  • 研發暨臨床醫學研究中心

Research, Development and Clinical Medical Research Center

  • 🏢地址:

974花蓮縣壽豐鄉大學路二段1號974國立東華大學創新育成中心1之10室

NDHU IIIC R1-10, No.1, Sec.2, Da Hsueh Rd., Shoufeng, Hualien 974, Taiwan (R.O.C.)

  • ☎電話:

+886-3-8630108

  • 📧email

efbiotech@efbiotech.com

 

  • 台北營運總部

Corporate Headquarters

  • 🏢地址:

103台北市大同區重慶北路二段178-3號2樓

2F, No.178-3, Sec.2, Chongqing N. Rd., Datong Dist., Taipei City 103 , Taiwan (R.O.C.)

  • ☎電話:
Copyright © 2023 Everfront Biotech Inc.. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.